Syngene International Share Price

Syngene International Investment Rating

• Master Rating:

• Syngene Inter has an operating revenue of Rs. 2,812.10 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 19% is great, ROE of 12% is good. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 1% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 89 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.